The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

Fri, 06th Sep 2019 07:54

* Dainippon to buy 10% stake in Roivant and interests in 5units

* Schizophrenia treatment Latuda to lose US exclusivity in2023

* Japan pharma firms grapple with declining population athome(Adds Dainippon CEO comment, context and stock price)

By Rocky Swift

TOKYO, Sept 6 (Reuters) - Japan's Sumitomo Dainippon PharmaCo will pay $3 billion for a 10% stake in Swissdrugmaker Roivant Sciences Ltd and interests in five of itsbiopharmaceutical businesses, the two companies said on Friday.

The deal, which will open up new drug lines for SumitomoDainippon, will also give it the option to acquire interests inan additional six businesses, as well as access to Roivant'stechnology platforms, they said in a statement.

It comes as Sumitomo Dainippon's schizophrenia treatmentLatuda is due to lose its U.S. market exclusivity in 2023. TheJapanese company will take ownership of Roivant units thatdevelop treatments for prostate cancer, urinary diseases,pediatric illnesses and respiratory diseases, they said.

"We look forward to deepening our relationship with Roivant,which has a rich development pipeline, technology platforms, anddistinctive talents," Sumitomo Dainippon CEO Hiroshi Nomura saidin the statement.

Like its rivals, Japan's seventh-largest pharma company byrevenue, is grappling with a declining population at home and aneed to go abroad to find growth.

While the bulk of Japanese drug firms have been largelycautious about overseas acquisitions, there are signs of change.Takeda Pharmaceutical this year completed a $59 billionpurchase of Shire Plc, catapulting it into the list of theworld's top 10 drugmakers by sales - a rarity for a Japanesepharma company.

A fifth Roivant business unit will also be transferredbefore the deal's conclusion, the two companies said.

The 11 businesses include more than 25 clinical programswith multiple product launches expected between 2020 and 2022,they said.

Shares of Sumitomo Dainippon finished up 1.7% at 1,800 yenon Friday.(Reporting by Rocky Swift; Editing by David Dolan andMuralikumar Anantharaman)

More News
4 Jan 2019 12:09

LONDON MARKET MIDDAY: Miners Keep FTSE Higher Ahead Of US Payrolls

LONDON (Alliance News) - Stocks in London remained higher midday Friday buoyed by miners, confirmed US-China trade talks and positive Chinese economic data.The FTSE 100 index was up 92.54 points,

Read more
6 Dec 2018 17:39

Oncimmune Appoints Former Tusk Therapeutics CFO Matthew Hall To Board

LONDON (Alliance News) - Cancer diagnostics firm Oncimmune Holdings PLC on Thursday said its has appointed former Tusk Therapeutics Ltd Chief Financial Officer Matthew Hall as finance will replace

Read more
5 Dec 2018 17:12

LONDON MARKET CLOSE: Stocks End Lower Amid Global Growth Fears

LONDON (Alliance News) - Stocks in London ended lower on Wednesday as concerns over global growth and trade wars continued to plague investors. The FTSE 100 index closed down 100.92 points, or at

Read more
5 Dec 2018 13:58

UPDATE: Takeda, Shire Secure Deal Approval From Shareholders

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 12:12

LONDON MARKET MIDDAY: Risk-Off Mood As Weak UK Services Adds To Worry

LONDON (Alliance News) - London stocks slid on Wednesday as risk-off sentiment replaced the more upbeat mood at start of the week, with markets in the US and Asia slumping overnight amid global of

Read more
5 Dec 2018 11:19

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical

Read more
5 Dec 2018 08:44

Asian Shares Fall On Trump-Xi Agreement Scepticism, US Treasury Yields

CANBERA (Alliance News) - Asian stocks ended broadly lower on Wednesday amid concerns over trade and worrying signals of economic health after the difference between three- and five-year US yields

Read more
5 Dec 2018 08:40

LONDON MARKET OPEN: Stocks Sink Amid Trade War, US Economy Jitters

LONDON (Alliance News) - With Monday's gains a distant memory, the FTSE 100 shed nearly 100 points at the London open Wednesday amid renewed global trade fears and worries over the strength of

Read more
5 Dec 2018 08:00

Takeda shareholders approve £46bn Shire takeover

(Sharecast News) - Takeda Pharmaceutical shareholders have approved its £46bn takeover of London-listed pharmaceutical group Shire.

Read more
5 Dec 2018 06:58

LONDON MARKET EARLY CALL: FTSE 100 Seen Down 60 Points After NY Fall

LONDON (Alliance News) - Stocks in London are set to open sharply lower on Wednesday following a slump in New York overnight that was tracked by Asian markets, with the optimism seen at the start

Read more
5 Dec 2018 06:43

TOP NEWS: Takeda Shareholders Approve Acquisition Of Shire

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 04:06

UPDATE 1-Takeda shareholders give nod for $59 bln Shire acquisition

* Deal is the biggest overseas acquisition by Japanese firm * Some had opposed massive debt required for deal * CEO Weber has promised to slash costs (Adds details about Takashi Dec

Read more
5 Dec 2018 03:32

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 (Reuters) - Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a but

Read more
2 Dec 2018 11:57

Sunday newspaper round-up: US-China, Brexit, Royal Mail, Barclays, Shire

(Sharecast News) - China and the United States have agreed to halt additional tariffs as both nations engage in new trade negotiations with the goal of reaching an agreement within 90 days, the White House said on Saturday after talks between President Donald Trump and President Xi Jinping in Argentina. - Sunday Telegraph

Read more
30 Nov 2018 08:35

Shire Wins European Okay For Takhzyro Drug Ahead Of January Delisting

LONDON (Alliance News) - Shire PLC said Friday its Takhzyro injection has been approved in Europe to treat hereditary angioedema.Takhzyro is a preventative treatment for hereditary a that a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.